BienRaíz has launched its latest supplement, BienRaíz D3 + K2, aimed at enhancing calcium utilization and promoting both skeletal and cardiovascular health. This new formula combines 5,000 IU of vitamin D3 with all-trans MK-7 vitamin K2, a highly bioavailable form derived from fermented sources, designed to work synergistically for optimal health outcomes.

The significance of this development lies in the growing body of evidence linking vitamin D3 and K2 in the regulation of calcium metabolism. Vitamin D3 is essential for calcium absorption, but without adequate K2, the body struggles to direct calcium into bone tissue effectively. This imbalance can lead to vascular calcification, a known risk factor for cardiovascular diseases. Current recommendations from health experts emphasize the importance of co-supplementation to mitigate these risks and enhance both bone density and arterial flexibility.

The introduction of BienRaíz D3 + K2 could shift current paradigms in supplement formulation and clinical practice. By providing a lipid-based formulation that maximizes absorption when taken with food, this product addresses the needs of populations at higher risk for deficiencies, such as individuals with limited sun exposure or those over 40. This product not only supports ongoing research into the synergistic effects of vitamins D3 and K2 but also sets a precedent for future developments in nutraceuticals aimed at optimizing healthspan and longevity.

Source: globenewswire.com